Patria Investments

Patria Investments is one of the largest alternative asset managers in Latin America, with public listing on Nasdaq, multi-strategy AUM in the tens of billions, and a long-standing private equity practice that has backed specialty healthcare clinics and providers across Brazil. Patria writes growth cheques at $25M+ and structures both control buyouts and significant minority positions in mid-market healthcare platforms, including specialty clinic chains, diagnostic networks, and pharma supply assets. The fund is decisively not an AI-thesis investor; its edge is operational consolidation, multi-asset roll-ups, and back-office professionalisation. Founders running revenue-generating clinic networks or specialty providers with ten-plus locations and clear EBITDA who want a partner to fund and execute regional consolidation should approach; software, AI, and Seed-stage digital health founders should not. The credible entry path is via a sell-side banker (BTG Pactual, Itau BBA, Bradesco BBI), a Big Four healthcare deals partner, or a Patria portfolio CEO. In a first meeting, lead with audited financials, segment-level EBITDA, regulatory licensing, supplier and payer concentration, and a clear roll-up pipeline; come prepared to discuss governance, board composition, and management equity structures, because Patria will expect a controlled cap table. Caveats: as a PE shop, Patria will price discipline and underwriting, not founder-friendly minority economics, so expect drag-along, ratchet, and significant management commitments. Brazil’s macro environment, FX risk, and SUS-versus-private payer dynamics will all be probed, so bring a defensible view. Cycle times are months, not weeks, and the firm prefers proprietary deal flow over auctions, so an early off-market conversation often beats a banker-run process if you can secure the warm introduction.